Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02721849
Other study ID # 15-6736
Secondary ID
Status Completed
Phase N/A
First received March 17, 2016
Last updated July 24, 2017
Start date April 2016
Est. completion date July 2017

Study information

Verified date July 2017
Source Universität Duisburg-Essen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized controlled trial to investigate the efficacy of yoga on tension type headache and / or migraine in adolescents between 12 and 16 years, consisting of a four group design which includes an 12 week yoga course and a three-month follow-up period. Both adolescent and one parent will be randomized either to yoga or no treatment. Primary outcome will be pain frequency in adolescents considering pain catastrophizing of parents.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date July 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 12 Years to 16 Years
Eligibility Inclusion Criteria:

Adolescent:

- tension type headache and/or migraine minimum at 4 days per month

- willingness to participate at least 10 out of 12 yoga sessions

- physical and cognitive ability to participate in light physical, breathing and relaxation exercises

- good german language

Parents:

- willingness to participate at least 10 out of 12 yoga sessions

- physical and cognitive ability to participate in light physical, breathing and relaxation exercises

- good german language

Exclusion Criteria:

- pregnancy or lactation

- attending a yoga class within the last 3 months prior to the study

Study Design


Intervention

Behavioral:
Yoga for adolescents
12 week hatha yoga course for adolescents
Yoga for parents
12 week hatha yoga course

Locations

Country Name City State
Germany Elisabeth Krankenhaus Essen
Germany Kinderkrankenhaus St. Marien Landshut

Sponsors (1)

Lead Sponsor Collaborator
Universität Duisburg-Essen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain frequency adolescent Measurement of pain frequency after yoga intervention via headache diary Week 12
Secondary Pain frequency adolescent Measurement of pain frequency after follow-up period via headache diary Week 24
Secondary Pain duration adolescent Measurement of pain duration after yoga intervention via headache diary Week 12
Secondary Pain duration adolescent Measurement of pain duration after follow-up period via headache diary Week 24
Secondary Pain intensity adolescent Measurement of pain intensity after yoga intervention via headache diary Week 12
Secondary Pain intensity adolescent Measurement of pain intensity after follow-up period via headache diary Week 24
Secondary Quality of life adolescent self-assessment Measurement of quality of life in self-assessment after yoga intervention via the kidscreen 27 questionnaire Week 12
Secondary Quality of life adolescent self-assessment Measurement of quality of life in self-assessment after follow-up period via the kidscreen 27 questionnaire Week 24
Secondary Quality of life adolescent external assessment Measurement of quality of life in external assessment by one parent after yoga intervention via the kidscreen 27 questionnaire Week 12
Secondary Quality of life adolescent external assessment Measurement of quality of life in external assessment by one parent after follow-up period via the kidscreen 27 questionnaire Week 24
Secondary Pain disability adolescent self-assessment Measurement of pain disability in self-assessment after yoga intervention via the paediatric pain disability index (P-PDI) Week 12
Secondary Pain disability adolescent self-assessment Measurement of pain disability in self-assessment after follow-up period via the paediatric pain disability index (P-PDI) Week 24
Secondary Pain disability adolescent external assessment Measurement of pain disability in external assessment by one parent after yoga intervention via the paediatric pain disability index (P-PDI) Week 12
Secondary Pain disability adolescent external assessment Measurement of pain disability in external assessment by one parent after follow-up period via the paediatric pain disability index (P-PDI) Week 24
Secondary Pain coping adolescent Measurement of pain coping in self-assessment after yoga intervention via the Paediatric Pain Coping Inventory Revise (PPCI-R) Week 12
Secondary Pain coping adolescent Measurement of pain coping in self-assessment after follow-up period via the Paediatric Pain Coping Inventory Revise (PPCI-R) Week 24
Secondary Depression adolescent Measurement of Depression in self-assessment after yoga intervention via the Depressions Inventar für Kinder und Jugendliche (DIKJ) Week 12
Secondary Depression adolescent Measurement of Depression in self-assessment after follow-up period via the Depressions Inventar für Kinder und Jugendliche (DIKJ) Week 24
Secondary Stress adolescent Measurement of Stress in self-assessment after yoga intervention via the Problem Questionnaire (PQ) Week 12
Secondary Stress adolescent Measurement of Stress in self-assessment after follow-up period via the Problem Questionnaire (PQ) Week 24
Secondary Pain catastrophizing parents Measurement of parents pain catastrophizing in self-assessment by one parent after follow-up period via the Pain Catastrophizing Scale for Parents (PCS-P) Week 12
Secondary Pain catastrophizing parents Measurement of parents pain catastrophizing in self-assessment by one parent after follow-up period via the Pain Catastrophizing Scale for Parents (PCS-P) Week 24
Secondary Quality of life parents Measurement of parents quality of life in self-assessment by one parent after yoga intervention via the WHO Quality of Life Bref questionnaire (WHOQol-Bref) Week 12
Secondary Quality of life parents Measurement of parents quality of life in self-assessment by one parent after follow-up period via the WHO Quality of Life Bref questionnaire (WHOQol-Bref) Week 24
Secondary Depression parents Measurement of parents depression in self-assessment by one parent after yoga intervention via the Beck-Depression-Inventar (BDI) Week 12
Secondary Depression parents Measurement of parents depression in self-assessment by one parent after follow-up period via the Beck-Depression-Inventar (BDI) Week 24
Secondary Stress parents Measurement of parents stress in self-assessment by one parent after yoga intervention via the Cohen's Perceived Stress Scale (PSS-10) Week 12
Secondary Stress parents Measurement of parents stress in self-assessment by one parent after follow-up period via the Cohen's Perceived Stress Scale (PSS-10) Week 24
Secondary Adverse events adolescent Adverse events within the yoga course period of adolescents Week 12
Secondary Adverse events parents Adverse events within the yoga course period of parents Week 12
See also
  Status Clinical Trial Phase
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Completed NCT05525611 - Cabergoline as a Preventive Treatment for Chronic Migraine N/A
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Not yet recruiting NCT06428838 - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Phase 3
Completed NCT06304675 - Manageable Environmental Factors in Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05517200 - Pilot Study for a Machine Learning Test for Migraine
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Active, not recruiting NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A